The import of vaccines for human use to Japan is forecasted to gradually decrease from $403.03 million in 2024 to $400.89 million in 2028. In 2023, imports stood at $403.03 million. The year-on-year variation shows a stable decline, suggesting minimal fluctuations. Over the five-year period, the compound annual growth rate (CAGR) reflects a slight downward trend.

Future trends to watch for include:

Potential changes in domestic vaccine production and its impact on import demand.
Global factors affecting vaccine supply chains and pricing volatility.
Japan’s healthcare policy shifts and their influence on vaccine imports.
Emerging health threats or pandemics that could alter vaccine needs.